Table 1. Characteristics of patients with Leishmania infantum infections.
Patient | Age (year) | Sex | History of visceral leishmaniasis (VL) | No. of lesions | Location of lesions | Type of lesions | Treatment of Lesions• | Cured/failure | Diagnosis | ||
Parasitology•• | Serology | Nested-PCR | |||||||||
1 | 2 | Male | Negative | 1 | Face | Nodule | Yes | Cured | 1+ | Negative | L. infantum |
2 | 1 | Female | Negative | 1 | Face | Ulcer | Yes | Cured | 4+ | Negative | L. infantum |
3 | 4 | Male | Positive | 1 | Face | Ulcer | Yes | Cured | 2+ | 1:3200 | L. infantum |
4 | 4 | Female | Positive | 1 | Face | Ulcer | Yes | Cured | 4+ | 1:3200 | L. infantum |
5 | 5 | Male | Negative | 1 | Face | Ulcer | Yes | Cured | 2+ | Negative | L. infantum |
6 | 3 | Male | Negative | 1 | Face | Ulcer | Yes | Cured | 2+ | Negative | L. infantum |
7 | 4 | Female | Negative | 1 | Face | Ulcer | Yes | Cured | 3+ | Negative | L. infantum |
8 | 1 | Male | Negative | 1 | Face | Ulcer | Yes | Cured | 2+ | Negative | L. infantum |
• Treatment with meglumine antimoniate (Glucantime®) drug (20 mg/kg for 14–28 days IM and/or intra lesions).
••Parasitemia grade.
Bold indicates innovations.